Skip to main content

NU Tech Roundtable: Agriculture will win the CRISPR race

The successes expected from CRISPR-Cas systems “Will come first in agriculture,” said North Carolina University food scientist, Rodolphe Barrangou, Ph.D., at the 8th annual NU-Tech Roundtable.

NU Tech Roundtable: Dynamic change coming in Ag Tech

The next five years will see more dynamic changes in agriculture technology than seen in the last 25 years, said John Dombrosky, CEO of the Ag Tech Accelerator at the 8th annual NU Tech Roundtable.

NIH Puts $4.1 million in Dignify's Bladder, Bowel Therapy

Dignify Therapeutics, a drug development company focused on restoring bladder and bowel control for the elderly and for people with spinal injury, multiple sclerosis or diabetes, continues to draw federal grants from the National Institutes of Health for its research and development.

BioIVT Buys Durham's Qualyst Transporter Solutions

BioreclamationIVT, a New York company that sells biospecimens and related services, primarily for drug safety testing, has purchased Durham’s Qualyst Transporter Solutions for an undisclosed sum.
 

Getting Down to the Roots of Breeding Better Corn

Duke University scientist Philip Benfey, Ph.D., has co-founded his second startup company, Durham-based Hi Fidelity Genetics, to use data on roots to breed and sell corn seed with desirable traits.

Innovate Gets Orphan Status for Pediatric Ulcerative Colitis Drug

Raleigh-based Innovate Biopharmaceuticals has received U.S. Food and Drug Administration orphan drug designation for an experimental oral drug to treat pediatric ulcerative colitis.

GSK’s Jack Bailey: NCBiotech Roots Launch High-Profile Career in Big Pharma

Jack Bailey, president of U.S. Pharmaceuticals for GlaxoSmithKline, says an internship he served at the Biotech Center was a major influence in his successful career as a global pharmaceutical company leader.

FDA Approves Bioventus’ Therapy for Knee Pain

Durham-based Bioventus, a global orthobiologics company, has received approval from the U.S. Food and Drug Administration to market Durolane, a single-injection joint lubricant for treating pain from knee osteoarthritis.

16 Bioscience Companies Awarded $1 Million in State Grants

Sixteen life science companies throughout North Carolina have received just over $1 million in grants from a state program to support their development of new technologies and products.

$100 Early Discount Ends Friday for SEBIO Forum in Pinehurst

Investors and other life science professionals have just a few more days to register at a discounted price for the 2017 SEBIO Investor and Partnering Forum in Pinehurst this fall.

Pages

Subscribe to RSS - Business & Commercialization